Fig. 2From: Intermittent fasting during adjuvant chemotherapy may promote differential stress resistance in breast cancer patientsA comparison between the two examined groups concerning glucose (mg/dl) and insulin (µIU/ml) levels after cycle 4. A shows a significant increase in median glucose levels in the non-fasting (NF) group compared to the intermittent fasting (IF) group after cycle 4. B shows a significant increase in median insulin levels in the NF group compared to the IF group after cycle 4. Information is displayed by the box-and-whisker plot. **P < 0.01 and ***P < 0.001 vs. the other groupBack to article page